Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Other Non-Current Assets (2024 - 2026)

Lite Strategy (LITS) posted Other Non-Current Assets of $678000.0 for Q1 2026, down 3.83% on a QoQ basis from $705000.0 in Q4 2025.

Analysis

Lite Strategy (LITS) Other Non-Current Assets (2024 - 2026) Analysis & Trends

Lite Strategy has reported Other Non-Current Assets for 3 years, with the latest figure at $678000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $678000.0 in Q1 2026; TTM through Mar 2026 was $678000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $263000.0, changed N/A from the prior year.
  • Other Non-Current Assets was $678000.0 for Q1 2026 at Lite Strategy, down from $705000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $732000.0 in Q3 2025, with the low at $263000.0 in Q2 2024.
  • Average Other Non-Current Assets over 3 years is $528200.0, with a median of $678000.0 recorded in 2026.
  • The largest YoY upside for Other Non-Current Assets was 178.33% in 2025 against a maximum downside of 178.33% in 2025.
  • Over 3 years, Other Non-Current Assets stood at $263000.0 in 2024, then surged by 168.06% to $705000.0 in 2025, then declined by 3.83% to $678000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $678000.0 (Q1 2026), $705000.0 (Q4 2025), and $732000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - 678,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 678,000.00
Dec 31, 2025 705,000.00
Sep 30, 2025 732,000.00
Sep 30, 2024 263,000.00
Jun 30, 2024 263,000.00